Truist Cuts Price Target on Cognex to $74 From $78, Keeps Hold Rating

Truist reduced its price target for Cognex from $78 to $74, maintaining a Hold rating. The company's stock closed at $64.97, up 4.42% on the Nasdaq. The change reflects adjustments in valuation and earnings per share revisions.

Original reporting
Published Oct 5, 2026, 12:09 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 1:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CGNX
Bearish
high confidence
Mentioned
$CGNX
Relevance
6/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$CGNXBearishMed
01

Why it matters

The downgrade could trigger short‑term selling pressure, but longer‑term fundamentals remain unchanged.

02

Market read

Analyst target change is a primary catalyst for Cognex's stock movement today.

03

What to watch

Potential upside from upcoming product launches or contract wins not reflected in the target.

Relevance 6/10Novelty 6/10Timing: pre‑market today

Background

Truist's research note adjusts Cognex's valuation based on recent performance and outlook.

Company-level read

Ticker impact

$CGNXBearishHigh confidence
Context

Truist lowered its price target for Cognex to $74 from $78, indicating a revised valuation outlook.

Expected impact

likely pressure as the market prices in the lower target

Evidence & confidence

A price‑target reduction directly signals reduced upside, prompting traders to reassess long positions.

Market effects

May weigh on other industrial automation stocks as analysts reassess sector valuations.

Limited to U.S. equities; no broader regional effect.

Minimal global impact beyond Cognex and peers.

Counterpoint

Some investors may view the target cut as an opportunity if they believe the market overreacted.

Key entities

  • Cognex

    Industrial automation and machine vision equipment maker.

  • Truist

    Financial services firm providing equity research.

Related articles

$CGNXMed

Cognex, Insight Enterprises, and SAIC Stocks Trade Down, What You Need To Know

Cognex (CGNX), Insight Enterprises (NSIT), and SAIC (SAIC) fell 4%, 3.8%, and 2.8% respectively, as September inflation rose to 3.7%, surpassing expectations and driving bond yields higher. Elevated inflation and interest rates may compress valuations, particularly in growth sectors like technology. Cognex's volatility continues, with shares down 20.5% from their 52-week high. Truist lowered its price target for Cognex to $74, maintaining a Hold rating.

$CGNXMed

CGNX Maintained by Barclays -- Price Target Raised to $85.00

Barclays maintained an Overweight rating on Cognex (CGNX) and raised its price target to $85.00 from $80.00. The company's GF Value™ suggests it is 15.6% overvalued, while its GF Score™ is 86/100. Cognex is a leading manufacturer of machine vision systems, with a market cap of $10.38 billion. Insider activity shows mixed sentiment, with some gurus adding positions while others trimmed.

$CGNXMed

Why Cognex (CGNX) Stock Is Falling Today

Cognex (CGNX) shares fell 7.5% due to rising Treasury yields, oil prices, and a Truist price target cut to $74. The company's stock is volatile, up 67.5% YTD but down 14.6% from its 52-week high. Truist expects constructive company commentary despite near-term challenges.

$CGNXHighAI 9/10

Shifting to physical AI, Cognex to acquire RealSense in $500 million deal

Cognex Corporation is acquiring RealSense, an Israeli AI vision technology developer, for $500 million in cash and a $50 million stock option. The deal, expected to close in Q4 2026, will expand Cognex into robotic perception and Physical AI. RealSense, with 180 employees, is a key supplier for autonomous robots and expects $80-90 million in 2026 revenue, up over 50% year-over-year.